Infectious Diseases Immunity

作者对稿件内容（包括由生成式人工智能生成的部分）承担全部责任；使用生成式人工智能的作者应开放、透明、详细地说明其使用情况（包括工具名称与版本、使用时间、使用方式和使用过程，必要时对涉及事实与观点的AI辅助内容加以标注），并对生成式AI内容进行审阅，说明位置为正文之后、参考文献之前或方法部分。 模型中文摘要

Authors are fully responsible for the content of their manuscript, even those parts produced by GenAI. Authors who have used GenAI in their research and the writing of manuscripts should provide an open, transparent, and detailed description of the use of GenAI (including the name and version of the GenAI tool, when it was used, how it was used, and the process of using it, and, if necessary, anno…

IDI期望每位署名作者在智力内容、数据分析或稿件撰写方面有充分参与，以承担公开责任；每位作者必须审阅稿件、确信其代表有效工作并批准投稿。 模型中文摘要

IDI expects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.

作者必须在稿件中声明所有可能的利益冲突，包括财务、顾问、机构及其他可能导致偏倚或利益冲突的关系；如无利益冲突也应明确声明为none declared；所有资金来源应在稿件中致谢，相关利益冲突与资金来源应以“Conflicts of Interest”和“Funding”为标题列入标题页。 模型中文摘要

Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources …

自2023年1月起，IDI要求所有报告基于研究数据所得结果的论文提供数据可用性声明，该声明将作为发表条件予以核实；声明应说明支持论文结果的数据可从何处获取（如适用，提供公开存档数据集的链接），若数据未公开，须在稿件中说明并写明访问数据的条件。 模型中文摘要

IDI requires authors to include a Data Availability Statement in any articles that report results derived from research data, from Jan 2023. The provision of a Data Availability Statement will be verified as a condition of publication. Data Availability Statements should include information on where data supporting the results reported in the article can be found including, where applicable, hyper…

中华医学会（CMA）拥有该期刊发表的任何文章的全部版权。 模型中文摘要

The Chinese Medical Association (CMA) is the owner of all copyrights to any articles published in the journal.

该期刊发表的每篇同行评议研究论文均以开放获取形式发表，发表后即可通过互联网永久免费获取；期刊不收取投稿、处理或出版费用（包括照片彩色复制费用），开放获取费用由中华医学会支付。 模型中文摘要

Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs. The Chinese Medi…

IDI采用双盲外部同行评审流程，审稿人与作者互不知晓对方身份。 模型中文摘要

IDI operates a double-blind external peer review process, where in the reviewers and authors are unaware of each other’s identity. Brief introduction on editorial review process of the journal:

抄袭的定义依据世界医学编辑联合会（WAME）的规定。 模型中文摘要

As defined by the World Association of Medical Editors (https://www.wame.org/resources):

作者需遵循期刊列出的相关报告指南。 模型中文摘要

The following reporting guidelines need to be followed by authors: